123 related articles for article (PubMed ID: 6099640)
1. Observations on the stability of foot and mouth disease vaccine antigens.
Anderson EC; Doughty WJ; Muthiani A
Vaccine; 1983 Dec; 1(1):26-30. PubMed ID: 6099640
[TBL] [Abstract][Full Text] [Related]
2. Variation in the thermal stability of isolates of foot-and-mouth disease type SAT 2 and its significance in the selection of vaccine strains.
Anderson EC; Doughty WJ; Spooner PR
J Comp Pathol; 1982 Oct; 92(4):495-507. PubMed ID: 6296205
[No Abstract] [Full Text] [Related]
3. Comparison of chemical extraction methods for determination of 146S content in foot-and-mouth disease oil-adjuvanted vaccine.
Saravanan P; Iqbal Z; Selvaraj DPR; Aparna M; Umapathi V; Krishnaswamy N; Tamilselvan RP
J Appl Microbiol; 2020 Jan; 128(1):65-73. PubMed ID: 31562676
[TBL] [Abstract][Full Text] [Related]
4. [The effectiveness of foot-and-mouth disease vaccines in Switzerland. II. Stability problems].
Ackermann M; Müller HK; Bruckner L; Kihm U
Schweiz Arch Tierheilkd; 1989; 131(7):389-95. PubMed ID: 2552580
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between 146S antigen dosage and antibody titers after foot-and-mouth disease vaccination in cattle and swine].
Liebermann HT; Thalmann G; Nöckler A; Felfe P
Arch Exp Veterinarmed; 1988 Jul; 42(4):528-36. PubMed ID: 2847677
[No Abstract] [Full Text] [Related]
6. Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus.
Cartwright B; Chapman WG; Brown F
J Gen Virol; 1980 Oct; 50(2):369-75. PubMed ID: 6257825
[TBL] [Abstract][Full Text] [Related]
7. International bank for foot-and-mouth disease vaccine: stability studies with virus concentrates and vaccines prepared from them.
Doel TR; Pullen L
Vaccine; 1990 Oct; 8(5):473-8. PubMed ID: 2174597
[TBL] [Abstract][Full Text] [Related]
8. Rapid correlation between field isolates and vaccine strains of foot-and-mouth disease virus.
Kitching RP; Rendle R; Ferris NP
Vaccine; 1988 Oct; 6(5):403-8. PubMed ID: 2848376
[TBL] [Abstract][Full Text] [Related]
9. The effect of acetylethyleneimine upon a strain of inactivated foot-and-mouth disease virus stored at 4 degrees C.
Staple RF; Morrow AW; Fletton BW
Arch Virol; 1975; 47(4):331-5. PubMed ID: 166627
[TBL] [Abstract][Full Text] [Related]
10. Stability and immunogenicity of empty particles of foot-and-mouth disease virus.
Rweyemamu MM; Terry G; Pay TW
Arch Virol; 1979; 59(1-2):69-79. PubMed ID: 218538
[TBL] [Abstract][Full Text] [Related]
11. A study on the immune response of sheep to foot and mouth disease virus vaccine type 'O' prepared with different inactivants and adjuvants.
Nair SP; Sen AK
Acta Virol; 1992 Oct; 36(5):473-8. PubMed ID: 1364024
[TBL] [Abstract][Full Text] [Related]
12. Attempts at potency testing of foot-and-mouth disease vaccines by evaluation of the complement fixing capacity of eluates.
Bauer K
Dev Biol Stand; 1976; 35():297-300. PubMed ID: 198299
[TBL] [Abstract][Full Text] [Related]
13. The suitability of the 'emergency' foot-and-mouth disease antigens held by the International Vaccine Bank within a global context.
Barnett PV; Samuel AR; Statham RJ
Vaccine; 2001 Feb; 19(15-16):2107-17. PubMed ID: 11228383
[TBL] [Abstract][Full Text] [Related]
14. Quantification of intact 146S foot-and-mouth disease antigen for vaccine production by a double antibody sandwich ELISA using monoclonal antibodies.
Van Maanen C; Terpstra C
Biologicals; 1990 Oct; 18(4):315-9. PubMed ID: 2178351
[TBL] [Abstract][Full Text] [Related]
15. Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines.
Pay TW; Hingley PJ
Vaccine; 1987 Mar; 5(1):60-4. PubMed ID: 3033928
[TBL] [Abstract][Full Text] [Related]
16. No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration.
Tekleghiorghis T; Weerdmeester K; van Hemert-Kluitenberg F; Moormann RJ; Dekker A
Vaccine; 2014 Sep; 32(41):5330-6. PubMed ID: 25092634
[TBL] [Abstract][Full Text] [Related]
17. A foot-and-mouth disease vaccine for swine.
McKercher PD; Bachrach HL
Can J Comp Med; 1976 Jan; 40(1):67-74. PubMed ID: 187292
[TBL] [Abstract][Full Text] [Related]
18. Preparation of virus-infection-associated (VIA) antigen of foot-and-mouth disease (FMD) virus from inactivated vaccine.
Sugimura T; Tsuda T; Suzuki T; Murakami Y
J Vet Med Sci; 1996 Jun; 58(6):599-601. PubMed ID: 8811637
[TBL] [Abstract][Full Text] [Related]
19. The stability and potency of vaccines prepared from inactivated foot-and-mouth disease virus concentrates.
Doel TR; David DJ
J Biol Stand; 1984 Jul; 12(3):247-55. PubMed ID: 6090464
[TBL] [Abstract][Full Text] [Related]
20. Developments in foot-and-mouth disease vaccines.
Barteling SJ; Vreeswijk J
Vaccine; 1991 Feb; 9(2):75-88. PubMed ID: 1647575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
